Literature DB >> 29876988

Reactive oxygen species-mediated phosphorylation of p38 signaling is critically involved in apoptotic effect of Tanshinone I in colon cancer cells.

Dong Hee Kim1, Eun Ah Shin1, Bonglee Kim1, Bum Sang Shim1, Sung-Hoon Kim1.   

Abstract

Though Tanshinone I (Tan I), a phenolic compound from Salvia miltiorrhiza, is known to have anticancer activity in several cancers, its anticancer mechanisms are not fully understood in colon cancer cells. Thus, in the present study, the underlying molecular mechanism of Tan I was explored in HCT116 and HT29 colorectal cancer cells (CRCs). Here, Tan I suppressed viability in HCT116 and HT29 cells in a time- and dose-dependent manner. Also, Tan I increased the number of terminal deoxynucleotide transferase-mediated dUTP nick end labeling (TUNEL)-positive cells and sub-G1 population in HCT116 and HT29 cells. Consistently, Tan I cleaved poly (adenosine diphosphate-ribose) polymerase (PARP) and caspase-8, caspase-3, attenuated the expression of Bid and activated tBid as a caspase-8 substrate and activated phosphorylation of p38 MAPK in HCT116and HT29 cells. Of note, Tan I generated reactive oxygen species (ROS) and conversely an ROS scavenger, N-acetyl-L -cysteine, reversed ROS production, PARP cleavage, caspase-3 activation, and p38 MAPK phosphorylation induced by Tan I in HCT116 cells. Furthermore, p38 MAPK inhibitor SB203580 reduced cytotoxicity, increase of TUNEL-positive cells, cleavages of PARP and caspase-3 induced by Tan I in HCT116 cells. Overall, our findings for the first time suggest that ROS-dependent activation of p38 MAPK and caspase-3 is critically involved in Tan I induced apoptosis in CRCs as a potent anticancer agent.
Copyright © 2018 John Wiley & Sons, Ltd.

Entities:  

Keywords:  Tanshinone I; caspase-3; colon cancer; p38; reactive oxygen species

Mesh:

Substances:

Year:  2018        PMID: 29876988     DOI: 10.1002/ptr.6126

Source DB:  PubMed          Journal:  Phytother Res        ISSN: 0951-418X            Impact factor:   5.878


  5 in total

1.  The diaryl-imidazopyridazine anti-plasmodial compound, MMV652103, exhibits anti-breast cancer activity.

Authors:  Alexis Neumann-Mufweba; Serah Kimani; Saif Feroz Khan; Kelly Chibale; Sharon Prince
Journal:  EXCLI J       Date:  2022-04-04       Impact factor: 4.022

2.  Development of a caffeic acid-phthalimide hybrid compound for NADPH oxidase inhibition.

Authors:  Willian Henrique Dos Santos; Maurício Ikeda Yoguim; Regina Gomes Daré; Luiz Carlos da Silva-Filho; Sueli Oliveira Silva Lautenschlager; Valdecir Farias Ximenes
Journal:  RSC Adv       Date:  2021-05-18       Impact factor: 4.036

3.  Tanshinone I inhibits the growth and metastasis of osteosarcoma via suppressing JAK/STAT3 signalling pathway.

Authors:  Weiguo Wang; Jinsong Li; Zhiyu Ding; Yuezhan Li; Jianlong Wang; Shijie Chen; Jinglei Miao
Journal:  J Cell Mol Med       Date:  2019-07-10       Impact factor: 5.310

Review 4.  Research and Development of Natural Product Tanshinone I: Pharmacology, Total Synthesis, and Structure Modifications.

Authors:  Xing Huang; Lili Jin; Hao Deng; Dan Wu; Qing-Kun Shen; Zhe-Shan Quan; Chang-Hao Zhang; Hong-Yan Guo
Journal:  Front Pharmacol       Date:  2022-07-11       Impact factor: 5.988

Review 5.  An overview of the anti-cancer actions of Tanshinones, derived from Salvia miltiorrhiza (Danshen).

Authors:  Irum Naz; Myriam Merarchi; Shanaya Ramchandani; Muhammad Rashid Khan; Muhammad Nouman Malik; Sumaira Sarwar; Acharan S Narula; Kwang Seok Ahn
Journal:  Explor Target Antitumor Ther       Date:  2020-06-29
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.